There may be new information. This information does not take the place of talking with your doctor about your condition or treatment. If you have questions about Testim, ask your doctor or healthcare provider.
Testim is a prescription medicine approved for use in adult males, 18 years and older, to treat hypogonadism, a medical condition that occurs when the body does not make enough testosterone.
Testim must not be used by women or children. Do not use Testim if you have breast or prostate cancer (if your doctor knows for sure or suspects it). Do not use Testim if you have a known allergy to any of its ingredients. The active ingredient is testosterone, which may be synthesized from soy. See the end of this leaflet for a complete list of ingredients in Testim. Do not use Testim if you have difficulty in urinating due to an enlarged prostate, or if you have serious liver, kidney, or heart disease.
Tell your doctor about all your medical conditions, including if you:
Tell your doctor about other medicines you are taking. Testim may affect how these medicines work, and you may need to have your doses adjusted. If you are a diabetic taking insulin, your doctor may need to adjust your insulin dose. Tell your doctor if you are taking medication to reduce the clotting of your blood. Be sure to tell your doctor if you are using Oxyphenbutazone, Propanolol, or Corticosteroids. Every patient is different.
Know all the medicines you take. Keep a list of them with you to show your doctor and pharmacist each time you get a new medicine.
Tell your doctor if you plan to father a child. Testosterone medicines such as Testim may reduce a man’s sperm count.
It is important that you do not spread the medicine to others, especially women and children. Be sure to wash your hands after applying Testim. To prevent transfer to another person, clothing should be worn to cover the application sites. Do not allow other persons to rub your skin where you have applied Testim, especially pregnant or nursing females, or children.
Testim may cause the following:
Medicines are sometimes prescribed for purposes other than those described in a patient information leaflet. Do not use Testim for a condition for which it was not prescribed. Do not give Testim to other people, even if they have the same symptoms that you have.
This page summarizes the most important information about Testim. If you would like more information, talk with your doctor or healthcare provider. They can answer your questions and give you the printed information about Testim that is written for health professionals.
Active ingredient: testosterone, USP (which may be synthesized from soy) Inactive ingredients: carbopol, pentadecalactone, acrylates, propylene glycol, glycerin, polyethylene glycol, alcohol, tromethamine, purified water.
Important Safety Information: Testim® is a prescription medicine used to treat hypogonadism, a medical condition that occurs when the body does not make enough testosterone. Only your doctor can decide if Testim is right for you. Testim should not be used by men with known or suspected cancer of the prostate or breast. Testim has not been approved or evaluated for use in women, and must not be used by women. Testosterone may cause fetal harm. Pregnant and nursing women, as well as children, should avoid skin contact with Testim application sites in men. In controlled clinical studies of Testim, the most common side effects reported were redness/irritation at the application site (4%) and above normal red blood cell count (2%).
Indication: Testim® is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Important Safety Information: Androgens are contraindicated in men with cancer known or suspected of the breast or prostate. Testim is not indicated for use in women, has not been evaluated for use in women, and must not be used in women. Testosterone may cause fetal harm. Pregnant and nursing women, as well as children, should avoid skin contact with Testim application sites. Geriatric patients treated with androgens may be at greater risk of prostatic hyperplasia and prostatic carcinoma.
Adverse Events: Adverse events reported at a level greater than 1% that were possibly or definitely related to the use of Testim in controlled clinical trials (N=304) across all dose groups were application site reaction (4%) and increase in hematocrit/hemoglobin (2%).